FDA Inspection
Robins, Edwin MD, PSRobins, Edwin MD, PS – FDA Inspection, Sep 13, 2022
Record Details
This FDA Inspection record concerns Robins, Edwin MD, PS, with an inspection on September 13, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Robins, Edwin MD, PS
- Inspection Date
- September 13, 2022
- Product Type
- Biologics
View Company Profile
ID · bc1e8e8c-bac4-4ee0-bb02-c1faad77e8f6
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1180602
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Robins, Edwin MD, PS
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | Not classified | Seattle District Office | |
| April 12, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 24, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 18, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 8, 2010 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Robins, Edwin MD, PS
- FDA Inspection 1273223 - 2025-06-13
- FDA Inspection 1006801 - 2017-04-12
- FDA Inspection 934244 - 2015-06-24
- FDA Inspection 791248 - 2012-07-18
- FDA Inspection 660613 - 2010-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.